NCT00488995View on ClinicalTrials.gov

Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

July 31, 2007

Conditions

Human Immunodeficiency Virus

Interventions

DRUG

CP-675,206

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY